[13] By 2006, Konynenburg had developed and presented what is now known as Rich's Protocol
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
As shown in Figure 6 , these options include dietary changes, the use of probiotics and prebiotics, antibiotic treatments, and even fecal transplantation
Patients should also review their health history and previous weight loss attempts with their healthcare provider to determine if Mounjaro is suitable for them
If genetic testing would help optimize your response, the Precision Peptide Genetic Test ($99 add-on) maps your GLP-1 receptor sensitivity and other peptide pathways to personalize your treatment plan